Release Date: 20/08/15 08:37 Summary: Appendix 3Y- Change of Director's Interest-Leon Pretorius Price Sensitive: No Download Document 31.34KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status